Inventor · disambiguated record
Alexander Alanine
Also filed as: ALANINE ALEXANDER
38 granted patents·5 pending applications·443 citations·filing 1997–2021
98Inventor score
Top patents by PatentIndex Score
43 records- 0195US6521754B2Benzothiazole derivatives with activity as adenosine receptor ligandsHOFFMANN LA ROCHE·Filed 2001·Granted Feb 18, 2003·53 cites·12 claims
- 0291US6407094B1Glutamate receptor antagonistsHOFFMANN LA ROCHE·Filed 2000·Granted Jun 18, 2002·52 cites·7 claims
- 0390US6509328B1Glutamate receptor antagonistsHOFFMANN LA ROCHE·Filed 2000·Granted Jan 21, 2003·34 cites·7 claims
- 0490US6451819B2Heterocyclic compounds useful as NMDA receptor selective subtype blockersHOFFMANN LA ROCHE·Filed 2001·Granted Sep 17, 2002·43 cites·18 claims
- 0588US11098080B2Peptide macrocycles against Acinetobacter baumanniiHOFFMANN LA ROCHE·Filed 2018·Granted Aug 24, 2021·3 cites·16 claims
- 0688US6963000B2Benzothiazole derivatives with activity as adenosine receptor ligandsHOFFMANN LA ROCHE·Filed 2002·Granted Nov 8, 2005·20 cites·24 claims
- 0786US7317007B2Benzothiazole derivatives with activity as adenosine receptor ligandsHOFFMANN LA ROCHE·Filed 2005·Granted Jan 8, 2008·5 cites·9 claims
- 0886US6265426B1Triazole derivativesHOFFMANN LA ROCHE·Filed 2000·Granted Jul 24, 2001·30 cites·14 claims
- 0984US10030047B2Peptide macrocycles against acinetobacter baumanniiHOFFMANN LA ROCHE·Filed 2016·Granted Jul 24, 2018·2 cites·51 claims
- 1084US7151098B2Glutamate receptor antagonistsHOFFMANN LA ROCHE·Filed 2006·Granted Dec 19, 2006·5 cites·27 claims
- 1183US6835732B2Benzothiazole derivatives with activity as adenosine receptor ligandsHOFFMANN LA ROCHE·Filed 2002·Granted Dec 28, 2004·11 cites·18 claims
- 1282US6831087B2Pyridine substituted isoquinoline derivativesHOFFMANN LA ROCHE·Filed 2002·Granted Dec 14, 2004·12 cites·23 claims
- 1382US6339093B1Isoquinoline derivativesHOFFMANN LA ROCHE·Filed 2000·Granted Jan 15, 2002·17 cites·15 claims
- 1481US11066443B2Anti-bacterial peptide macrocycles and use thereofHOFFMANN LA ROCHE·Filed 2018·Granted Jul 20, 2021·3 cites·5 claims
- 1580US6432985B2Neuroprotective substituted piperidine compounds with activity as NMDA NR2B subtype selective antagonistsHOFFMANN LA ROCHE·Filed 2001·Granted Aug 13, 2002·13 cites·11 claims
- 1679US6610723B2Imidazole derivativesHOFFMANN LA ROCHE·Filed 2001·Granted Aug 26, 2003·10 cites·25 claims
- 1778US7018998B2Glutamate receptor antagonistsHOFFMANN LA ROCHE·Filed 2005·Granted Mar 28, 2006·2 cites·5 claims
- 1878US6310213B1Ethanesulfonyl-piperidine derivativesHOFFMANN LA ROCHE·Filed 2000·Granted Oct 30, 2001·11 cites·16 claims
- 1976US6440995B1Quinolin-4-yl derivativesHOFFMANN LA ROCHE·Filed 2000·Granted Aug 27, 2002·10 cites·35 claims
- 2076US5889026A4-hydroxy-piperodine derivativesHOFFMANN LA ROCHE·Filed 1997·Granted Mar 30, 1999·37 cites·22 claims
- 2174US7576088B2Benzodioxole derivativesHOFFMANN LA ROCHE·Filed 2005·Granted Aug 18, 2009·2 cites·16 claims
- 2273US6900227B2Benzodioxole derivativesHOFFMANN LA ROCHE·Filed 2003·Granted May 31, 2005·7 cites·15 claims
- 2372US6960578B2Glutamate receptor antagonistsHOFFMANN LA ROCHE·Filed 2002·Granted Nov 1, 2005·4 cites·5 claims
- 2472US6407235B1Prodrug acid esters of [2-(4-benzyl-3-hydroxy-piperidin-1-yl)-ethansulfonyl]phenolHOFFMANN LA ROCHE·Filed 2001·Granted Jun 18, 2002·6 cites·18 claims
- 2570US2010075959A1Benzothiazole derivatives with activity as adenosine receptor ligandsALANINE ALEXANDER·Filed 2009·Application pending·0 cites
- 2668US12012466B2Peptide macrocycles against Acinetobacter baumanniiHOFFMANN LA ROCHE·Filed 2021·Granted Jun 18, 2024·0 cites·5 claims
- 2768US6730670B27-phenyl-benzo[b]thiophen amide derivativesHOFFMANN LA ROCHE·Filed 2002·Granted May 4, 2004·3 cites·16 claims
- 2867US6683097B2Imidazole derivativesHOFFMANN LA ROCHE·Filed 2003·Granted Jan 27, 2004·2 cites·25 claims
- 2966US7034044B2Conjugated aromatic compounds with a pyridine substituentHOFFMANN LA ROCHE·Filed 2003·Granted Apr 25, 2006·2 cites·13 claims
- 3065US2008108809A1Benzothiazole derivatives with activity as adenosine receptor ligandsALANINE ALEXANDER·Filed 2007·Application pending·0 cites
- 3165US2008125419A1Benzothiazole derivatives with activity as adenosine receptor ligandsALANINE ALEXANDER·Filed 2007·Application pending·0 cites
- 3260US2005026906A1Benzothiazole derivatives with actitvity as adenosine receptor ligandsFiled 2004·Application pending·0 cites
- 3355US6667335B2Imidazole derivativesHOFFMANN LA ROCHE·Filed 2003·Granted Dec 23, 2003·0 cites·6 claims
- 3455US2006058354A1Conjugated aromatic compounds with a pyridine substituentALANINE ALEXANDER·Filed 2005·Application pending·0 cites
- 3554US6951875B2Conjugated aromatic compounds with a pyridine substituentHOFFMANN LA ROCHE·Filed 2002·Granted Oct 4, 2005·0 cites·13 claims
- 3654US6184236B1Method of treating a neurodegenerative disease by administering an aryl-cyclohexylamine derivativeHOFFMANN LA ROCHE·Filed 1999·Granted Feb 6, 2001·11 cites·14 claims
- 3753US6359138B14-hydroxy-piperidine derivativesHOFFMANN LA ROCHE·Filed 1997·Granted Mar 19, 2002·10 cites·2 claims
- 3852US7790733B28-alkoxy or cycloalkoxy-4-methyl-3,4-dihydro-quinazolin-2-ylaminesHOFFMANN LA ROCHE·Filed 2006·Granted Sep 7, 2010·0 cites·24 claims
- 3948US6153624APyrrolidine and piperidine derivatives and treatment of neurodegenerative disordersHOFFMAN LAROCHE INC·Filed 1999·Granted Nov 28, 2000·6 cites·9 claims
- 4047US7790732B25-Chloro-4-alkyl-3,4-dihydro-quinazolin-2-ylamine derivativesHOFFMANN LA ROCHE·Filed 2006·Granted Sep 7, 2010·0 cites·24 claims
- 4147US6071929AOctahydro phenanthridine derivatives useful as NMDA-R receptor subtype blockersHOFFMANN LA ROCHE·Filed 1999·Granted Jun 6, 2000·6 cites·21 claims
- 4246US6015824APyrrolidine and piperidine derivatives and treatment of neurodegenerative disordersHOFFMANN LA ROCHE·Filed 1999·Granted Jan 18, 2000·5 cites·5 claims
- 4346US5952344ATetrahydroisoquinoline derivativesHOFFMANN LA ROCHE·Filed 1998·Granted Sep 14, 1999·6 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Alexander Alanine files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →